Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification and evaluation of candidate COVID-19 critical genes and medicinal drugs related to plasma cells

3 Oct 2024

Abstract excerpt

The ongoing COVID-19 pandemic, caused by the SARS-CoV-2 virus, represents one of the most significant global health crises in recent history. Despite extensive research into the immune mechanisms and therapeutic options for COVID-19, there remains a paucity of studies focusing on plasma cells. In this study, we utilized the DESeq2 package to identify differentially expressed genes (DEGs) between COVID-19 patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Phagocytosis and Immune Regulation
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39363208
DOI: 10.1186/s12879-024-10000-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification and evaluation of candidate COVID-19 critical genes and medicinal drugs related to plasma cellsPMID 39363208Read ↗

Systems Biology and Bioinformatics approach to Identify blood based signatures molecules and drug targets of patient with COVID-19Semantic proximity Read ↗

Identification of key genes related to immune cells in patients with COVID-19 via Integrated Bioinformatics-Based AnalysisSemantic proximity Read ↗

Identification of potentional immunological biomarkers of COVID-19 by blood transcriptome analysisSemantic proximity Read ↗

Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 PandemicSemantic proximity Read ↗

Computational Profiling of Inflammatory and Coagulation Responses in COVID-19 via RNA-SeqSemantic proximity Read ↗

Identification of immune-related hub genes and potential molecular mechanisms involved in COVID-19 via integrated bioinformatics analysisSemantic proximity Read ↗

Identification of Transcriptome Biomarkers for Severe COVID-19 with Machine Learning MethodsSemantic proximity Read ↗

COVID-19: A Drug Repurposing and Biomarker Identification by Using Comprehensive Gene-Disease Associations through Protein-Protein Interaction Network AnalysisSemantic proximity Read ↗

Bioinformatics and machine learning approach identifies potential drug targets and pathways in COVID-19Semantic proximity Read ↗

Transcriptome and SARS-CoV-2 biological network directed analysis for better therapeutic developmentSemantic proximity Read ↗

Comprehensive Analysis of the Systemic Transcriptomic Alternations and Inflammatory Response during the Occurrence and Progress of COVID‐19Semantic proximity Read ↗

Identification of key molecules in COVID-19 patients significantly correlated with clinical outcomes by analyzing transcriptomic dataSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.